From Name:
From Email:
To Name:
To Email:

Optional Message:

Doptelet now available for thrombocytopenia in chronic liver disease

from Monthly Prescribing Reference

Dova announced the launch of Doptelet (avatrombopag) for the treatment of thrombocytopenia in adults with chronic liver disease who are undergoing a procedure. Doptelet, a second-generation, oral thrombopoietin (TPO) receptor agonist, was initially approved by the U.S. Food and Drug Administration in May. The drug works by stimulating the proliferation and differentiation of megakaryocytes from bone marrow progenitor cells resulting in an increased production of platelets. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063